Search

Your search keyword '"Ganjoo, Kristen N."' showing total 13 results
Start Over Author "Ganjoo, Kristen N." Publisher american society of clinical oncology
13 results on '"Ganjoo, Kristen N."'

1. Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Author

Gounder, Mrinal M., Razak, Albiruni Abdul, Somaiah, Neeta, Chawla, Sant, Martin-Broto, Javier, Grignani, Giovanni, Schuetze, Scott M., Vincenzi, Bruno, Wagner, Andrew J., Chmielowski, Bartosz, Jones, Robin L., Riedel, Richard F., Stacchiotti, Silvia, Loggers, Elizabeth T., Ganjoo, Kristen N., Le Cesne, Axel, Italiano, Antoine, Garcia del Muro, Xavier, Burgess, Melissa, and Piperno-Neumann, Sophie

Published
2022
Full Text
View/download PDF

2. Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1.

Author

Chawla, Sant P, Van Tine, Brian A, Pollack, Seth M, Ganjoo, Kristen N, Elias, Anthony D, Riedel, Richard F, Attia, Steven, Choy, Edwin, Okuno, Scott H, Agulnik, Mark, von Mehren, Margaret, Livingston, Michael B, Keedy, Vicki L, Verschraegen, Claire F, Philip, Tony, Bohac, G Chet, Yurasov, Sergey, Yakovich, Adam, Lu, Hailing, and Chen, Michael

Published
2022
Full Text
View/download PDF

4. Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma.

Author

Van Tine, Brian Andrew, Eulo, Vanessa, Toeniskoetter, Jacqui, Ruff, Tyler, Luo, Jingqin, Kemp, Lindsey, Moreno Tellez, Cristiam, Weiss, Mia C., Hirbe, Angela C., Meyer, Christian Frederick, Elias, Anthony D., Diamond, Mark, Hartner, Lee P., Bui, Nam, Ganjoo, Kristen N., Maki, Robert G., and Wilky, Breelyn A.

Published
2023
Full Text
View/download PDF

5. Phase 2, multicenter, open-label basket trial of nab -sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).

Author

Iyer, Gopa, Deming, Dustin A., Demeure, Michael J., Federman, Noah, McKean, Meredith, Lee, Elizabeth Katherine, Spira, Alexander I., Kwiatkowski, David J., Hussein, Maen A., Gordon, Erlinda Maria, Crockett, David G., Ganjoo, Kristen N., Schulte, Brian, Cranmer, Lee D., Ding, Li, Schmid, Anita N., Navarro, Willis H., and Rodon Ahnert, Jordi

Published
2023
Full Text
View/download PDF

6. The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma.

Author

D'Angelo, Sandra P., Ganjoo, Kristen N., Blay, Jean-Yves, Valverde, Claudia, Araujo, Dejka M., Abdul Razak, Albiruni Ryan, Le Cesne, Axel, Schuetze, Scott, Wagner, Michael J, Attia, Steven, Forcade, Edouard, Druta, Mihaela, Pollack, Seth, Bai, Jane, Lunt, Colin, Sun, Amy, Yule, Murray, McAlpine, Cheryl, Williams, Dennis, and Van Tine, Brian Andrew

Published
2023
Full Text
View/download PDF

7. The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma.

Author

Van Tine, Brian Andrew, Ganjoo, Kristen N., Blay, Jean-Yves, Valverde, Claudia, Araujo, Dejka M., Abdul Razak, Albiruni Ryan, Le Cesne, Axel, Schuetze, Scott, Wagner, Michael J, Attia, Steven, Forcade, Edouard, Druta, Mihaela, Pollack, Seth, Bai, Jane, Bayer, Paige, Van Winkle, Erin, Norry, Elliot, McAlpine, Cheryl, Williams, Dennis, and D'Angelo, Sandra P.

Published
2023
Full Text
View/download PDF

8. Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).

Author

Deming, Dustin A., Rodon Ahnert, Jordi, Demeure, Michael J., Federman, Noah, McKean, Meredith, Lee, Elizabeth Katherine, Spira, Alexander I., Kwiatkowski, David J., Hussein, Maen A., Gordon, Erlinda Maria, Crockett, David G., Ganjoo, Kristen N., Schulte, Brian, Cranmer, Lee D., Schmid, Anita N., Navarro, Willis H., Itri, Loretta Marie, and Iyer, Gopa

Published
2023
Full Text
View/download PDF

10. Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma.

Author

Levy, Ronald, Ganjoo, Kristen N., Leonard, John P., Vose, Julie M., Flinn, Ian W., Ambinder, Richard F., Connors, Joseph M., Berinstein, Neil L., Belch, Andrew R., Bartlett, Nancy L., Nichols, Craig, Emmanouilides, Christos E., Timmerman, John M., Gregory, Stephanie A., Link, Brian K., Inwards, David J., Freedman, Arnold S., Matous, Jeffrey V., Robertson, Michael J., and Kunkel, Lori A.

Published
2014
Full Text
View/download PDF

11. R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study.

Author

Pappo, Alberto S., Patel, Shreyaskumar R., Crowley, John, Reinke, Denise K., Kuenkele, Klaus-Peter, Chawla, Sant P., Toner, Guy C., Maki, Robert G., Meyers, Paul A., Chugh, Rashmi, Ganjoo, Kristen N., Schuetze, Scott M., Juergens, Heribert, Leahy, Michael G., Geoerger, Birgit, Benjamin, Robert S., Helman, Lee J., and Baker, Laurence H.

Published
2011
Full Text
View/download PDF

12. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center.

Author

Porter, Julie Bryar, Rosenthal, Eben Lloyd, Winget, Marcy, Smith, Andrea Segura, Seshadri, Sridhar Belavadi, Vetteth, Yohan, Kiamanesh, Eileen F., Badwe, Amogh, Advani, Ranjana H., Buyyounouski, MarkK, Coutre, Steven, FrederickDirbas, VasuDivi, Dorigo, Oliver, Ganjoo, Kristen N., Johnston, Laura J., Recht, Lawrence David, Shrager, Joseph B., Skinner, Eila C., and Swetter, Susan M.

Subjects
*TUMOR diagnosis, *ACADEMIC medical centers, *AUTOMATION, *BIOMETRY, *CANCER patients, *CONTINUUM of care, *ECONOMICS, *GOAL (Psychology), *HEALTH care teams, *LEADERSHIP, *MEDICAL care, *MEDICAL care cost control, *MEDICAL quality control, *ONCOLOGISTS, *ONCOLOGY, *PATIENTS, *REPORT writing, *SURGEONS, *SURVIVAL, *TREATMENT effectiveness, *ACQUISITION of data, *DATA analysis software
Abstract

Purpose Development and implementation of robust reporting processes to systematically provide quality data to care teams in a timely manner is challenging. National cancer quality measures are useful, but the manual data collection required is resource intensive, and reporting is delayed. We designed a largely automated measurement system with our multidisciplinary cancer care programs (CCPs) to identify, measure, and improve quality metrics that were meaningful to the care teams and their patients. Methods Each CCP physician leader collaborated with the cancer quality team to identify metrics, abiding by established guiding principles. Financial incentive was provided to the CCPs if performance at the end of the study period met predetermined targets. Reports were developed and provided to the CCP physician leaders on a monthly or quarterly basis, for dissemination to their CCP teams. Results A total of 15 distinct quality measures were collected in depth for the first time at this cancer center. Metrics spanned the patient care continuum, from diagnosis through end of life or survivorship care. All metrics improved over the study period, met their targets, and earned a financial incentive for their CCP. Conclusion Our quality program had three essential elements that led to its success: (1) engaging physicians in choosing the quality measures and prespecifying goals, (2) using automated extraction methods for rapid and timely feedback on improvement and progress toward achieving goals, and (3) offering a financial team-based incentive if prespecified goals were met. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results